vee vlp
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 17, 2018 (NCT03776994)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
- Alphavirus Infections · Phase 1
- Brain Diseases · Phase 1
- Central Nervous System Diseases · Phase 1
- Central Nervous System Infections · Phase 1
- Central Nervous System Viral Diseases · Phase 1
- Encephalitis · Phase 1
- Encephalitis, Viral · Phase 1
- Encephalomyelitis · Phase 1
- Encephalomyelitis, Equine · Phase 1
- Encephalomyelitis, Venezuelan Equine · Phase 1
- Infectious Encephalitis · Phase 1
- Nervous System Diseases · Phase 1
- Physiological Effects of Drugs · Phase 1
- RNA Virus Infections · Phase 1
- Togaviridae Infections · Phase 1
- Vaccines · Phase 1
- Virus Diseases · Phase 1
Mechanism of action
- Venezuelan equine encephalitis virusImmunity, active
Venezuelan equine encephalitis virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03776994 | Phase 1 | Jul 17, 2018 | SRI International, United States Army |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| SRI International | Academic/Hospital | 1 | 1 | 1 | 2018 |
| United States Army | Government | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1